Abstracts tagged "Psychosocial factors and systemic sclerosis"

Abstract Number: 2161 • 2013 ACR/ARHP Annual Meeting
Biopsychosocial Typologies of Pain in a Cohort of Patients With Systemic Sclerosis
Erin L. Merz¹, Vanessa L. Malcarne¹, Shervin Assassi², Deepthi Nair², Tiffany Graham², Brayden Yellman², Rosa M. Estrada-Y-Martin³ and Maureen D. Mayes², ¹SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, ²Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, ³Pulmonary and Critical Care Medicine, University of Texas Health Science Center at Houston, Houston, TX
Background/Purpose: Despite being a common problem in Systemic Sclerosis, the extant literature on pain has primarily focused on biomedical correlates, or bivariate relationships with a…
Abstract Number: 908 • 2013 ACR/ARHP Annual Meeting
Appearance Dissatisfaction, Social Discomfort, and Helplessness In Patients With Systemic Sclerosis
Shadi Gholizadeh¹, Sarah D. Mills², Rina M. Sobel-Fox¹, Philip J. Clements³, Suzanne Kafaja⁴, Vanessa L. Malcarne^2,5, Dinesh Khanna⁶ and Daniel Furst⁴, ¹Psychology, SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, ²SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, ³University of California, Los Angeles, Department of Medicine, Los Angeles, CA, ⁴David Geffen School of Medicine, UCLA, Los Angeles, CA, ⁵Department of Psychology, San Diego State University, Psychology, San Diego, CA, ⁶Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI
Background/Purpose: Systemic sclerosis (SSc) is a progressive, autoimmune disease with no known cure. It is related to a wide spectrum of adverse health outcomes including…
Abstract Number: 2626 • 2012 ACR/ARHP Annual Meeting
The Utility of the Patient Health Questionnaire-9 to Assess Suicide Risk in Patients with Systemic Sclerosis
Ilya Razykov¹, Marie Hudson², Murray Baron³ and Brett D. Thombs¹, ¹Psychiatry, McGill University, Montreal, QC, Canada, ²Jewish General Hospital, McGill University, Montreal, QC, Canada, ³Pavillion A, Rm 216, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada
Background/Purpose: Depression is common in rheumatic diseases, including systemic sclerosis (SSc). In the general population, depression is associated with suicidal ideation, attempts and completion. The…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].